Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
Sponsor: Ohio State University
Terminated
interruption of study enrollment and procedures due to COVID-19 health crisis
This NA trial investigates Blood Glucose, High and Blood Glucose, Low and is currently terminated or withdrawn. Ohio State University leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Mar 2024 — Jul 2024 [monthly]
Terminated NA
Status: Completed → Terminated
-
Jun 2021 — Mar 2024 [monthly]
Completed NA
-
Jan 2021 — Jun 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2019 — Oct 2020 [monthly]
Recruiting NA
-
Sep 2018 — Oct 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2018 — Sep 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University
For direct contact, visit the study record on ClinicalTrials.gov .